| Lammertz, Marion (Ayoxxa Biosystems 201504 Marketing Manager Communications) |
Sales Manager / Marketing Manager |
Ayoxxa (Group) |
Germany |
| Lamotte, André (HBM BioVentures 200505) |
n. a. |
HBM (Group) |
Switzerland |
| Lamottke, Kai (Bicoll 201308 Managing Director * Founder) |
Managing Director |
Bicoll (Group) |
Germany |
| Lamottke, Maria (Bicoll 202211) |
Board member, non-executive |
Bicoll (Group) |
China |
| Lamp, Anne K. (Traceless Materials 202309 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Traceless Materials GmbH |
Germany |
| Lampert, Mark (Biotechnology Value Fund 201009 Founder) |
Investment Manager |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
| Lampeter, Eberhard F. (Vita 34 1997–201205 Chairman of Management Board RESIGNED 6/12) |
Chief Executive Officer (CEO) |
Vita 34 (Group) |
Germany |
| Lamraoui, Hamid (UroMems 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
UroMems (FR) |
France |
| Lamzin, Victor |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Lancaster, Madeline (MRC LMB 201908 Principal Researcher + Co-Founder of a:head bio) |
Researcher (university / research institute) |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Lanckriet, Heikki (Expedeon 201111 CEO + Founder) |
Chief Executive Officer (CEO) |
2invest (Group) |
United Kingdom (GB) |
| Land, Jörg (Sonormed 201502 Managing Director) |
Managing Director |
Sonormed GmbH |
Germany |
| Lander, Eric (Broad Institute 200607 Director) |
n. a. |
MIT (Massachusetts Institute of Technology) |
United States (USA) |
| Lander, Maik (R-Biopharm 201904– Managing Director Development + Manufacturing at Progen Biotechnik GmbH joined 2016) |
Managing Director |
R-Biopharm (Group) |
Germany |
| Lander, Victoria V. (Vicky) (Bruker 201207–201408 Global Director of Marketing Communciations) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Landich, Rainer (HotSwap 201102 Managing Director HotSwap Lübeck GmbH) |
Managing Director |
HotSwap (Group) |
Germany |
| Landis, Camille A. (T-Knife 202101– CBO + CFO before Unity Biotechnology + Eidos Therapeutics + Relypsa) |
Chief Business Officer (CBO) |
T-Knife (Group) |
Germany |
| Landlinger-Schubert, Christine (PhagoMed 201910c– Director of Lysin Programme before Affiris) |
n. a. |
BioNTech (Group) |
Austria |
| Landry-Lane, Janis (IBM 201304 Director World-wide Deep Computing) |
n. a. |
IBM (Group) |
United States (USA) |
| Landschütze, Volker (aevotis 201011 Managing Director) |
Managing Director |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
| Landt, Olfert (GenExpress GmbH 201102 Managing Director + TIB Molbiol 200312–2009– Managing Director) |
Managing Director |
TIB Molbiol (Group) |
Germany |
| Landwehr, Jörg (ActeaVentures 201403– Managing Partner before ActeaPartnering + PharmaMar + Roche) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Lane, Laura (Eli Lilly 202307 VP Venture Sciences Europe formerly VirionHealth 201710– COO) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Lanero Fidalgo, Michaël (TreeFrog Therapeutics 202002– COO before Merck KGaA France + GSK Belgium) |
Chief Operating Officer (COO) |
TreeFrog Therapeutics (Group) |
France |
| Lang, Christine (OrganoBalance GmbH –201807 Managing Director + Founder STEPPED DOWN 7/18) |
Managing Director |
Novozymes (Group) |
Germany |
| Lang, Stefan (ImmunoPrecise 202110 CBO formerly Aldevron 201112 Aldevron Freiburg GmbH) |
Chief Business Officer (CBO) |
ImmunoPrecise (Group) |
Canada |
| Lang, Steffen (Novartis 201803 Global Head Technical Operations joined 1994) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Lang, Vera (MC Services 202303) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Langbehn, Annette (Biocom AG 201405) |
n. a. |
Biocom (Group) |
Germany |
| Langbein, Christian (Prof. Fett & Partner 200809 Ulm) |
n. a. |
Prof. Fett & Partner (Ulm) |
Germany |
| Lange, Bodo M. H. (Alacris Theranostics GmbH 201202 Managing Director) |
Managing Director |
Alacris Theranostics GmbH |
Germany |
| Lange, Christian (Accelero Bioanalytics GmbH 201506 Managing Partner) |
Managing Partner |
Accelero Bioanalytics – Marion Ellermann |
Germany |
| Lange, Dirk T. (Merck (DE) 202202– EVP Global Head of Life Science Services at MilliporeSigma before JSR Corp) |
Chief Executive Officer (CEO) |
MilliporeSigma (business unit of Merck KGaA) |
United States (USA) |
| Lange, Josef (Niedersachsen (govt) 201101 Secretary of State Ministry of Education and Culture) |
Administrative Officer (personnel) |
Niedersachsen (govt region) |
Germany |
| Lange, Sandra (Sachsen (govt) 202208 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Saxony (govt region) |
Germany |
| Lange, Stephan (Boehringer Ingelheim 201908 Head Animal Health for Greater China) |
Regional manager |
Boehringer Ingelheim (Group) |
Germany |
| Langen, Hanno (Roche 200902 GLobal Head Protein Biomarker Technologies Roche Molecular Medicine Laboratories) |
Product Manager (personnel) |
Roche (Group) |
Switzerland |
| Langenegger, Lukas (Hemotune 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hemotune AG |
Switzerland |
| Langer, Christof (S-Target Therapeutics 201310 Managing Director + Co-founder) |
Managing Director |
S-Target Therapeutics GmbH |
Austria |
| Langer, Hans J. (EOS Group 1989–201910 CEO + Founder) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Germany |
| Langer, Julian D. (Max Planck 201606 MPI of Biophysics + MPI for Brain Research) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Langer, Ludger (MorphoSys 201312– Head of Clinical Operations + Project Management before PRA International) |
Clinical Research Manager |
Novartis (Group) |
Germany |
| Langer, Marie (EOS Group 201910– CEO of EOS GmbH) |
Chief Executive Officer (CEO) |
EOS Group (Electro Optical Systems) (Group) |
Germany |
| Langhärig, Jürgen (Evaxion Biotech 201910– Head of Business Development before Serodus) |
Business Development Manager / Strategy Manager |
Evaxion Biotech A/S (Nasdaq: EVAX) |
Denmark |
| Langner, Klaus-Dieter (Grünenthal 201609 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Grünenthal (Group) |
Germany |
| Langner, Stefan (Bruker 201308 Marketing Communications Manager at Bruker Nano Analytics division) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
|
| Langrehr, Philipp (Allogenetics 202409 Co-Founder) |
Company Founder |
Allogenetics GmbH |
Germany |
| Lankmayr, Karl (Austria (govt) 201510 CEO of aws Mittelstandsfonds) |
Chief Executive Officer (CEO) |
Austria (govt) |
Austria |
| Lansky, Frank |
n. a. |
2invest (Group) |
Germany |
| Lansky, Patrick (Yposkesi 202002– VP US Sales + Marketing before Cobra Biologics + Vetter-Pharma + Atlhea Technologies |
Sales Manager / Marketing Manager |
SK Group (Group) |
France |
| Lanthaler, Werner (Evotec AG 200903–202401 CEO before Intercell + Austrian Industrial Assoc + McKinsey RESIGNED 1/24) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Germany |
| Lapid, Henit (Lonza 202104 Head Mammalian Commercial Development + Marketing) |
Sales Manager / Marketing Manager |
Lonza (Group) |
Switzerland |
| Laplace, Frank (BMBF 200703) |
n. a. |
Germany (govt) |
Germany |
| LaPointe, Lawrence (Clinical Genomics 201708 CEO) |
Chief Executive Officer (CEO) |
Clinical Genomics (Group) |
Australia |
| Lappe, Mark (Inhibrx 201110 CEO + co-founder) |
Chief Executive Officer (CEO) |
Inhibrx Inc. (INBX) |
United States (USA) |
| Lapray, Damien (Hedera Dx 202210 CCO + Co-Founder before Sophia Genetics) |
Chief Commercial Officer (CCO) |
Hedera Dx S.A. |
Switzerland |
| Larkins, Bill (Hikma 202406 President of Hikma Injectables) |
President/Director/Head Business Group/Unit/Division |
Hikma (Group) |
United Kingdom (GB) |
| Larsen, Philip (SixPeaks Bio 202405 CEO before Bayer + Sanofi 201508 VP) |
Chief Executive Officer (CEO) |
SixPeaks Bio AG |
Switzerland |
| Laser, Bernd (InProcess Instruments + Vacutec 200908 Managing Director + Founder) |
Managing Director |
InProcess Instruments Gesellschaft für Prozessanalytik mbH (IPI) |
Germany |
| Lassen, Cheryl (Cytos Biotechnology 201303– VP Clinical Development before Novartis + BMS + Abbott + Pharmacia) |
Clinical Research Manager |
Kuros (Group) |
Switzerland |
| Last, Andrew J. (Andy) (Bio-Rad 201904– COO before Berkeley Lights + Intrexon + Affymetrix + BD Biosciences) |
Chief Operating Officer (COO) |
Bio-Rad (Group) |
United States (USA) |
| Lata, Vlad (Avi Medical 202204 Managing Director (CEO) + Co-Founder) |
Managing Director |
Avi Medical (Group) |
Germany |
| Latrille, Frank (Merck Serono 200701 Head of Product Development) |
n. a. |
Merck (DE) (Group) |
Switzerland |
| Latz, Eicke (Charité Berlin + DRFZ Berlin 202305– + Co-Founder of several companies + Univ Bonn) |
Professor |
Humboldt University Berlin |
Germany |
| Lauber, Wendy (Tecan 201109 Head Product Management for Liquid Handling + Consumables) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Laue, Carsten (Medipol 201108 Managing Director) |
Managing Director |
Medipol S.A. |
Switzerland |
| Laue, Hans-Jörg (Thermolinear 201006 Managing Director + Co-owner) |
Managing Director |
Thermolinear Isotopenmassenspektrometer GmbH |
Germany |
| Laugel, Thierry (Kurma Life Sciences Partners 201103 Managing Partner at Kurma BioFund before AGF Private Equity) |
Managing Partner (investment firm) |
Eurazeo (Group) |
France |
| Laughman, Keith (Viewics 201711 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Laukien, Frank H. (Bruker 201204 President + CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
| Laukien, Günther (Bruker founder) |
Company Founder |
Bruker (Group) |
United States (USA) |
| Laukien, Jörg C. (Bruker –201811 Board Member RETIRED 11/18) |
Board member, non-executive |
Bruker (Group) |
United States (USA) |
| Laurence, Nicole (Insempra 202405 Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Insempra GmbH |
Germany |
| Laurent, Jérémie (Astraveus 202306 CEO + Founder) |
Chief Executive Officer (CEO) |
Astraveus SAS |
France |
| Laurer, Christian (Niederösterreich (govt) 200511 Senior Investment Manager at Tecnet Equity) |
Investment Manager |
Niederösterreich (govt region) |
Austria |
| Lauter, Frank-Roman (Signature Diagnostics 200601– before Indivumed before GeneScan Europe before founde BioInside GmbH) |
n. a. |
Roche (Group) |
Germany |
| Lauterbach, Anja (Potsdam Science Park 202305 Office Management) |
Public Relations Manager / Investor Relations Manager |
Potsdam Science Park (Standortmanagement Golm GmbH) |
Germany |
| Lauterbach, Enise (Lemoa 202003– Managing Director + Founder) |
Managing Director |
Lemoa (Group) |
Germany |
| Lauterbach, Verena (CureVac GmbH 201603 Senior Director Communications) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
| Lautner, Christian (Heal Capital 202306 Founding Managing Partner + Eternity.Health 202107 MD + Co-Founder) |
Managing Director |
Heal Capital (Heal.Capital) (Group) |
|
| Lautscham, Georg (Protagen 201610– CEO before CBO) |
Chief Executive Officer (CEO) |
Freenome (Group) |
Germany |
| Laverty, Hugh (Innovative Medicines Initative 201704 Head of Scientific Operations) |
Cluster Manager |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
| Lavin, Mary (Sartorius 202109 President of Sartorius North America) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals) |
Chief Executive Officer (CEO) |
F2G (Group) |
United Kingdom (GB) |
| LaVoie, Donna L. (LaVoieHealthScience 201812 CEO) |
Chief Executive Officer (CEO) |
LaVoieHealthScience (LHS) |
United States (USA) |
| Law, Richard (Exscientia 202101– EVP Strategic Alliances before Evotec + UCSD + LLNL) |
Business Development Manager / Strategy Manager |
Recursion Pharmaceuticals (Group) |
United Kingdom (GB) |
| Lawlor, Bridie (FTI Consulting 202004) |
Public Relations Manager / Investor Relations Manager |
FTI Consulting (Group) |
United States (USA) |
| Lawrence, David (Valneva 201708– CFO before Acambis + Chiron Vaccines + GSK) |
Chief Financial Officer (CFO) |
Valneva (Group) |
France |
| Lawson, Jennifer (Sartorius 201901 Product Manager for Testing at Sartorius Stedim BioOutsource) |
Product Manager (personnel) |
Sartorius (Group) |
United Kingdom (GB) |
| Lawton, Vincent (Merck (US) former Managing Director of Merck Sharp & Dohme UK + VP MSD Europe) |
Managing Director |
Merck (US) (MSD) (Group) |
United Kingdom (GB) |
| Laxhuber, Ludwig A. |
n. a. |
Infineon (Group) |
Germany |
| Layton, David (Partners Group 2024 CEO) |
Chief Executive Officer (CEO) |
Partners Group (Group) |
Switzerland |
| Lazar, David E. (OpGen 202403– CEO + Private Investor) |
Chief Executive Officer (CEO) |
OpGen (Group) |
United States (USA) |
| Lazarus, Tadd S. (Qiagen 201301– CMO based in US before at Gen-Probe CMO) |
Chief Medical Officer (CMO) |
Qiagen (Group) |
United States (USA) |
| Le Brun, Stéphane(Innopsys 201303 CEO + Financial Director) |
Chief Executive Officer (CEO) |
Innopsys (Group) |
France |
| Le Meunier, Ludovic (Alcen 202402 CEO of Theryq) |
Chief Executive Officer (CEO) |
Alcen (Group) |
France |
| Leanderson, Tomas (Active Biotech 2008–201706 CEO joined 1999 LEFT 7/17) |
Chief Executive Officer (CEO) |
Active Biotech (Group) |
Sweden |
| Lebeaut, Alexandre (Ipsen 201811 EVP RnD + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ipsen (Group) |
France |
| Leber, Alexander (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
| Leder, Ethan D. (Precision for Medicine 2012– Executive Chairman + Co-Founder before United BioSource 200312 founder) |
Company Founder |
Precision Medicine Group (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 44 45 46 ... 91 92 93 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
